In his first joint address to Congress in 2021, President Joe Biden asked lawmakers to greenlight a new initiative: a health research agency focused on speeding to market innovative technologies for diseases like cancer and Alzheimer’s.
Shortly thereafter, a lobbying campaign was born.
Now, cities and states across the nation are jostling to become the site of the Advanced Research Projects Agency for Health by forming coalitions, hiring external lobbyists and recruiting lawmakers to the cause. The opportunity promises to be a potentially major economic boon to the winner.
